Lupin Limited Acquires HuminsulinⓇ: What This Means for the Indian Market
▫️Lupin Limited’s acquisition of HuminsulinⓇ from Eli Lilly in India is indeed a strategic move that aligns with its commitment to providing affordable healthcare solutions. By transitioning from a marketing partner to the brand owner, Lupin can leverage its robust distribution network, R&D capabilities, and market expertise to enhance access to advanced insulin options. ▫️Given … Read more
